UpScriptHealth has joined forces with Eversana on a digital platform that aims to improve patient access to therapies, and the experience that goes with it.
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS